Home › Triple-Negative Breast Cancer › New York › New Rochelle
Triple-Negative Breast Cancer clinical trials in New Rochelle, NY
5 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around New Rochelle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi away
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5 mi away
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison · 5 mi away
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
RecruitingPhase 2
- Memorial Sloan Kettering Westchester, Harrison · 5 mi away
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
RecruitingPhase 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in New Rochelle
- Breast Cancer38 studies
- Non-Small Cell Lung Cancer18 studies
- Prostate Cancer16 studies
- Multiple Myeloma14 studies
- Acute Myeloid Leukemia13 studies
- Bladder Cancer11 studies
- Lung Cancer11 studies
- Endometrial Cancer11 studies
- Metastatic Cancer10 studies
- Cancer (all types)10 studies
- Ovarian Cancer9 studies
- Cardiovascular Disease8 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.